Bcl-2 inhibitors (HQL Pharmaceuticals)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameBcl-2 inhibitors (HQL Pharmaceuticals)
Drug Alias Nameprotein-protein interaction inhibitors (HQL Pharmaceuticals)apoptosis stimulators (HQL Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis regulator Bcl-2 inhibitors
TargetsApoptosis regulator Bcl-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHQL Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHQL Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A